Home/Pipeline/OsStic™ Technology

OsStic™ Technology

Periarticular Fracture Fixation & Bone Repair

DevelopmentFDA Breakthrough Device (2023); In Development

Key Facts

Indication
Periarticular Fracture Fixation & Bone Repair
Phase
Development
Status
FDA Breakthrough Device (2023); In Development
Company

About Sanara MedTech

Sanara MedTech is a Texas-based medical technology company with a mission to improve clinical outcomes and reduce healthcare expenditures through transformative surgical and wound care products. The company has successfully commercialized a portfolio of regenerative medicine products for soft tissue repair and surgical site management, establishing a revenue-generating foundation. Its strategic focus is now on advancing its flagship OsStic™ bone bioadhesive technology, a high-potential platform with FDA Breakthrough Device Designation, while leveraging its commercial infrastructure for growth.

View full company profile